Rh Incompatibility in Pregnancy: Risks to the Fetus and Prevention with Rh Immune Globulin

The Problem

If mother is Rh-negative and fetus is Rh-positive (inherited from Rh+ father), fetal red cells can enter maternal circulation during pregnancy or delivery. Mother's immune system produces anti-D antibodies (IgG) that cross placenta and destroy fetal RBCs → Hemolytic Disease of the Fetus and Newborn (HDFN).

Consequences for Fetus/Newborn

  • Anemia: From RBC destruction.
  • Jaundice: Bilirubin from hemoglobin breakdown; risk of kernicterus (brain damage) if severe.
  • Hydrops fetalis: Severe anemia → heart failure, edema, ascites; can be fatal.
  • Long-term neurodevelopmental impairment from bilirubin toxicity.

Prevention: Rh Immune Globulin (RhIg / Rho(D) Immune Globulin)

  • Routine: 300 µg IM at 28 weeks gestation.
  • Post-delivery: Within 72 hours if newborn is Rh+.
  • After any sensitizing event: Amniocentesis, CVS, miscarriage, abortion, ectopic, trauma, bleeding.

RhIg binds fetal Rh+ cells in maternal circulation, preventing maternal antibody formation.

If Already Sensitized

RhIg is ineffective. Management: serial middle cerebral artery (MCA) Doppler for fetal anemia, intrauterine transfusion if needed, early delivery, phototherapy/exchange transfusion for newborn.

Success

RhIg has reduced HDFN incidence from ~10% to <0.1% in at-risk pregnancies.

Baby Health - Related Articles